COMMONLY REPORTED ADVERSE EVENTS ASSOCIATED WITH ANTICOAGULANTS USING FDA ADVERSE EVENT REPORTING SYSTEM DATABASE 2012-2018

被引：0
|
作者：
Costa, L. [1 ]
Hincapie, A. [1 ]
Guo, J. J. [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.684
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDG5
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [31] Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
    He, Chang-Zhu
    Qiu, Qin
    Lu, Song-Jie
    Xue, Fu-Li
    Liu, Jun-Qiao
    He, Yu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [32] Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database
    Kim, Hyunwoo
    Pfeiffer, Colin M.
    Gray, Matthew P.
    Stottlemyer, Britney A.
    Boyce, Richard D.
    Kane-Gill, Sandra L.
    RESPIRATORY CARE, 2021, 66 (11) : 1739 - 1745
  • [33] Spontaneous reporting of rare events associated with atypical antipsychotics using the FDA adverse event reporting system
    Emechebe, Nnadozie
    Mukhtar, Fahad
    Scheer, Darren
    Patel, Arshiya
    Wadhawan, Abhishek
    Schwartz, Skai
    Zgibor, Janice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 345 - 346
  • [34] Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system
    Cao, Bing
    Gu, Shanshan
    Shen, Zhisen
    Zhang, Yuna
    Shen, Yiming
    Chen, Hang
    EXPERT OPINION ON DRUG SAFETY, 2023, : 297 - 303
  • [35] SERIOUS ADVERSE DRUG EVENTS REPORTED TO THE FOOD AND DRUG ADMINISTRATION (FDA): ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) 2006-2011 DATABASE
    Sonawane, K. B.
    Hansen, R. A.
    VALUE IN HEALTH, 2015, 18 (03) : A86 - A86
  • [36] Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database
    Yin, Yi
    Jiang, Jie
    Jin, Youpeng
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [37] Ocular adverse events of cenegermin used in neurotrophic keratopathy: an analysis of the FDA adverse event reporting system database
    Li, Yunfei
    Yang, Haiyun
    Gao, Yuan
    He, Weimin
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (03) : 385 - 391
  • [38] Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study
    Li, Yun
    Li, Hang
    Xiang, Zhongyuan
    HELIYON, 2024, 10 (06)
  • [39] ADVERSE EVENTS ASSOCIATED WITH THE DAVINCI SURGICAL SYSTEM AS REPORTED IN THE FDA MAUDE DATABASE
    Gupta, Priyanka
    Schomburg, John
    Lund, Erik
    Adejoro, Olukawayode
    Konety, Badrinath
    JOURNAL OF UROLOGY, 2013, 189 (04): : E351 - E351
  • [40] Cardiovascular adverse events associated with parp inhibitors: A disproportionality analysis of FDA adverse event reporting system
    Viswam, Subeesh Kulangara
    Kheterpal, Aarushi
    Dhas, Ashwin
    Zeba, Zeba
    Shettigar, Amrutha
    Lukose, Lipin
    Kaur, Gursimran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 452 - 452
12345